SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sadot Group, Inc. operates as a restaurant chain business. It operates through the following segments: Muscle Maker Grill Restaurant, Pokemoto Hawaiian Poke Restaurant, Non-Traditional (Hybrid), SuperFit Foods Meal Prep, and Sadot. The firm offers protein- based meals featuring chicken, seafood, pasta, hamburgers, wraps and flat breads. It also provides salads, protein shakes and fruit smoothies. The company was founded by Rodney C. Silva in 2022 and is headquartered in Burleson, TX.

Sadot Group Inc

SDOT is trending due to increased attention on low float stocks and discussions around potential catalysts. The community is focused on the company's revenue, potential sale of restaurant assets, and its recent move into a Bitcoin treasury strategy. Traders are closely watching for a breakout, with some citing a possible short squeeze and others expressing skepticism.

Veritone, Inc. engages in the provision of artificial intelligence (AI) computing solutions to media and entertainment, government, and legal and compliance industries. It operates through the following segments: Advertising, aiWARE SaaS Solutions, and aiWARE Content Licensing and Media Services. The Advertising segment places advertisements for clients, primarily with radio broadcasters, podcasters and digital media producers. The aiWARE SaaS Solutions segment offers solutions through a combination of its direct sales force and indirect channel partners, such as value-added resellers (VARs), distributors, system integrators, managed services providers, and referral partners. The aiWARE Content Licensing and Media Services segment sells and markets activities relating to its digital content licensing services business through its direct sales force. The company was founded by Chad Edward Steelberg and Ryan S. Steelberg on June 13, 2014 and is headquartered in Denver, CO.

Veritone Inc

Veritone ($VERI) is trending following news of data refinery contract wins with leading hyperscalers, leading to community excitement and after-hours gains. The community highlights the stock's low market cap relative to its revenue, and some are speculating about future partnerships and a potential short squeeze. Some traders are taking profits while many express long-term bullish sentiment on this AI play.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amid excitement surrounding its upcoming Kraken listing on October 15th, with the community speculating on potential price surges and further exchange listings. Discussions are centered on institutional accumulation, staking benefits, and the potential for Zebec to disrupt traditional payroll systems. Some users express optimism for significant gains, while others debate market manipulation and optimal buying strategies.

Blaize Holdings, Inc. provides artificial intelligence solutions. It develops hardware computing platforms for augmented reality, drones, and automobiles. The company was founded by Dinakar C. Munagala, Satyaki Koneru, and Ke Yin in January 2010 and is headquartered in El Dorado Hills, CA.

Blaize Holdings Inc.

Blaize

BZAI is trending as investors discuss a potential upcoming contract announcement, speculating it could drive the stock price higher; some community members believe the stock is undervalued compared to its peers in the edge AI sector. Chatter revolves around its growth potential, with contracted revenues and strategic partnerships in Asia, though concerns about cash runway and potential dilution are also present. Some investors are closely monitoring the stock's technical indicators, anticipating a breakout.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company is trending as retail and institutional investors focus on rare earth minerals and domestic lithium supply. The completion of NEPA baseline studies for its Tonopah Flats Lithium Project in Nevada has generated community excitement, with some drawing comparisons to high-growth stocks like NVDA and speculating about potential government funding. Many who have held the stock for years are celebrating recent gains and anticipating further upside.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors digest recent news of increased competition in the AI chip space, particularly AMD's deal with OpenAI, sparking discussions about NVIDIA's dominance and potential impact on its valuation. Community members are weighing the significance of these developments, analyzing potential support levels, and speculating on future price movements. Broader market concerns, geopolitical tensions, and upcoming earnings are also contributing to the conversation surrounding the stock.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to renewed interest in metal recycling and potential short squeeze opportunities, with community members debating its long-term value and potential for further gains. The stock's volatile price action and low float are fueling discussions around quick profits and risks associated with potential dilutions. Sympathy plays in related sectors, like cooking oil recycling, are also gaining traction.

HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.

HCM II Acquisition Corp - Ordinary Shares - Class A

HCM II Acquisition Corp.

HOND is trending as investors are drawn to its potential in the nuclear energy sector, particularly its application in powering AI data centers. Community discussions highlight its upcoming merger and potential for significant growth, drawing comparisons to sector peers like OKLO. Some investors also believe the stock is being manipulated and that HOND is undervalued compared to its peers.

Avalon Holdings Corp. engages in the provision of waste management services to industrial, commercial, municipal, and governmental customers. It operates through the Waste Management Services and Golf and Related Operations segments. The Waste Management Services segment offers waste disposal brokerage and management services, captive landfill management operations, and salt water injection well operations. The Golf and Related Operations segment focuses on the operation and management of golf courses and related country clubs, hotels and resort amenities, athletic centers, and travel agencies. The company was founded on April 30, 1998 and is headquartered in Warren, OH.

Avalon Holdings Corp. - Ordinary Shares - Class A

Avalon Holdings Corp. 

AWX is trending as traders discuss its low float and potential for a squeeze, drawing comparisons to recent moves in similar stocks. Community members are speculating on potential catalysts related to recycling and government initiatives, as well as the company's underlying asset value.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst ($BCRX) is trending due to its acquisition of Astria Therapeutics, a deal that has sparked mixed reactions in the community; while some investors see the strategic value in expanding their HAE portfolio, others are concerned about the dilution and increased debt. Discussions revolve around the potential impact on share value, future profitability, and whether this move signals a shift away from a potential buyout. Community members are actively debating the long-term implications and questioning management's capital allocation decisions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Aligos Therapeutics (ALGS) Have the Potential to Rally 737.74% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 737.7% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

SNY wins FDA approval for Wayrilz, the first BTK inhibitor for immune thrombocytopenia, with broader rare disease studies underway.

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study

Rocket Pharmaceuticals' shares soar as the FDA lifts its clinical hold on the pivotal Danon disease gene therapy study.

Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 983.2% in Aligos Therapeutics (ALGS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Allogene's Q2 Loss Narrower Than Expected, Pipeline in Focus

ALLO posts a narrower second-quarter 2025 loss. The company advances multiple CAR T programs targeting cancer and autoimmune diseases.

Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, Aligos ), a clinical stage biopharmaceutical company focused on developing novel...

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, Aligos ), a clinical stage biopharmaceutical company focused on developing novel...

Aligos Therapeutics initiates Phase 2a HERALD study of ALG-055009

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aligos Therapeutics Announces the Initiation of the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

Screening of subjects has begun at clinical study sitesThe Phase 2a study is being led by Principal Investigator, Dr. Stephen HarrisonAligos anticipates dosing the first subject in Q2 2024 with...

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 5, 2018 and is headquartered in South San Francisco, CA.

Aligos Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$9.66
Prev Close	$9.47
Open	$9.18
Dividend Yield	0.00%
50-Day Moving Average	$9.64
Beta	1.67
Avg. Volume	64,691.48
PE Ratio	-0.48

52-Week High	$46.80
52-Week Low	$3.76
Market Capitalization	$58.25M
EPS (Annual)	-$20.94
Price to Book	0.57
Revenue Per Employee	$56,357.14
Enterprise Value/EBITDA	N/A

ALGS
Aligos Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALGS News

ALGSAligos Therapeutics Inc